This page shows the latest Glaxo SmithKline news and features for those working in and with pharma, biotech and healthcare.
There have been previous times when industry thinking was that bigger is better and major deals have been commonplace, notably at the turn of the 21st century, when Glaxo Wellcome merged ... News reports also hinted at patriotic reasons for the deal - an
It's a struggle to think then that this abbreviation has only been around for 14 years, when Glaxo Wellcome and SmithKline Beecham merged to become one of big pharma's ... According to the BBC in an article about the formation of GSK: 'Not wanting to be
It was this complex path that formed GlaxoSmithKline (which only 25 years ago was disparate entities SmithKline Beckman, Beecham Group, Glaxo and Wellcome) and Novartis (formerly Ciba-Giegy and Sandoz), not
As a graduate of Warsaw Medical Academy in Poland, Vaganova's professional career began with PwC Poland, where she was involved in supporting the Glaxo Wellcome and SmithKline Beecham merger.
GSK said it would also publish CSRs for clinical outcomes trials for all of its approved medicines, stretching back to the company's formation through the 2000 merger of Glaxo Wellcome ... and SmithKline Beecham.
His previous positions include the CEO of GSK following the merger of SmithKline Beecham and Glaxo Wellcome in 2001. ... Prior positions at SmithKline Beecham include president of the company's pharmaceutical business in North America, as well as
More from news
Approximately 0 fully matching, plus 12 partially matching documents found.
Garnier served as SmithKline Beecham's chief executive officer, having joined the company in 1990 as president of pharmaceuticals for North America. ... He subsequently became GSK's first CEO following its formation from the merger of Glaxo Wellcome and
Brings experience from Roche, Glaxo and SmithKline. Sygnature Discovery has appointed Dr Louis Nisbet to its board as a non-executive director. ... The UK-based clinical research organisation (CRO) will benefit from Dr Nisbet's extensive experience in
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Getting the best from your agency in a disruptive time. Multi-billion dollar mergers and acquisitions have always created headlines in pharma news, and it’s fair to say that the pharmaceutical industry probably experiences more of this type of
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...